Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$41,494,681
+$30,868,773 QoQ
Shares Held
164,897
+237.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#411
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $367,571,362 across 18 Drug Manufacturers - General names. ABBV ranks #4 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
326,790 | $82,994,856 | |
| 2 | MRK |
Merck & Co., Inc.
|
608,608 | $78,206,128 | |
| 3 | LLY |
ELI LILLY & Co
|
46,821 | $56,158,516 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
164,897 | $41,494,681 | |
| 5 | NVO |
Novo Nordisk A S
|
449,006 | $21,525,347 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
363,882 | $20,966,880 | |
| 7 | PFE |
Pfizer Inc
|
811,104 | $19,531,384 | |
| 8 | AMGN |
Amgen Inc
|
50,310 | $18,218,257 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,494,681 | 164,897 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $10,625,908 | 48,857 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $11,435,239 | 50,047 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,560,118 | 54,246 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,645,326 | 25,026 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,548,391 | 12,163 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,802,766 | 10,145 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,475,174 | 7,470 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,197,209 | 6,980 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,057,636 | 5,808 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,263,159 | 8,151 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,273,865 | 8,546 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $831,013 | 6,168 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $963,710 | 6,047 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $941,539 | 5,826 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $832,504 | 6,203 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $911,761 | 5,953 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $1,023,400 | 6,313 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $853,967 | 6,307 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $665,881 | 6,173 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $664,350 | 5,898 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $489,139 | 4,565 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $389,863 | 4,451 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $429,832 | 4,378 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $343,007 | 4,502 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||